Printer Friendly

KYTHERA Biopharmaceuticals, Inc. Selected to Present at InsideVenture's Debut Investor Conference.

March 25-26, Santa Barbara, California

LOS ANGELES -- KYTHERA Biopharmaceuticals, Inc. (KYTHERA) today announced that Keith Leonard, President and CEO, will present at InsideVenture's Debut Conference, March 25-26, 2009 in Santa Barbara, California. KYTHERA has been selected from over 170 nominations to be one of 50 top private companies showcased to long-term investors through presentations and 1-on-1 meetings at the invitation only conference. KYTHERA is a privately held biopharmaceutical company focused on developing and commercializing novel products in aesthetic medicine. The company aims to use the new financing platform to support additional private funding efforts. InsideVenture's Selection Boards includes Founders and Partners of leading venture firms including NEA, Venrock, DCM, Domain, Frazier, Clarus, Oak Investment, Aisling, and Versant. Over 130 investors are represented in the selected companies.

"We are honored to support KYTHERA in their private funding efforts through our online platform and at our debut transactional conference in Santa Barbara," said Mona DeFrawi, Chief Executive Officer of InsideVenture. "InsideVenture was created as a powerful and cost-effective platform to support the companies that grow our economy by facilitating their late stage and pre-IPO financing needs. Structural changes in the capital markets over the past 10 years have blocked the real path to economic growth by challenging the financing of the companies delivering valuable new products, jobs and profits for the world economy. These top 50 companies have invested in innovation, and now InsideVenture is innovating the investment process to support their continued growth."

KYTHERA announced in February that its investors elected early to exercise their rights to invest an additional $10 million as a part of a $40 million Series C financing. "We look forward to building relationships with high quality private investors through InsideVenture's new financing platform with a goal of further supporting our progress into late stage trials for ATX-101, an adipolytic agent for the reduction in small volumes of localized fat deposits," said Keith Leonard, President and CEO.

InsideVenture Investor Conference - March 25-26, Santa Barbara, California

KYTHERA is one of 50 top late-stage private healthcare and technology companies seeking to raise $20-200+M or establish and develop relationships with new investors prior to an eventual IPO. The companies will present their businesses to qualified institutional buyers (QIBs), including mutual fund managers, crossover funds, late stage VC & PE funds and strategic corporate investors. Investors interested in attending the conference may apply for an InsideVenture trial membership; the conference is exclusive to members and by invitation only. The theme of this year's conference is "Investing in Innovation: Innovation in Investing." Investors should contact InsideVenture today to apply for membership and an invitation to the InsideVenture Investor Conference, March 25-26, 2009 in Santa Barbara, California.

About KYTHERA Biopharmaceuticals, Inc.

KYTHERA is a privately held biopharmaceutical company that uses the tools of biotechnology to develop innovative prescription therapeutics for aesthetic medicine. KYTHERA has active programs in adipolysis, facial contouring and pigmentation modulation.

For more information about KYTHERA, please visit the company's Web site at www.kytherabiopharma.com.

About InsideVenture

InsideVenture is an industry sponsored financial marketing utility creating a direct private market platform for institutional and strategic investment in late-stage private companies. InsideVenture's exclusive vetting and membership requirements connect the best late-stage venture-backed companies with revered long-term institutional and strategic investors to facilitate late-stage transactions, IPO participation and aftermarket support. InsideVenture is supported by investment leaders and partners like T. Rowe Price, Wasatch Advisors, SVB Financial Group, NYSE, Alexandria Equities, Intralinks Corporation, New Enterprise Associates, Domain Associates, DCM, Venrock Associates, Versant Ventures, Frazier Healthcare Ventures, Clarus Ventures, and Aisling Capital among others. InsideVenture is based in Menlo Park, California and on the web at www.insideventure.com.
COPYRIGHT 2009 Business Wire
No portion of this article can be reproduced without the express written permission from the copyright holder.
Copyright 2009 Gale, Cengage Learning. All rights reserved.

 
Article Details
Printer friendly Cite/link Email Feedback
Publication:Business Wire
Article Type:Conference news
Date:Mar 24, 2009
Words:605
Previous Article:iLinc and SharePoint Integrated for Online Schools.
Next Article:Neolane Teams with IBM to Improve Marketing Effectiveness and Increase Customer Value.
Topics:

Terms of use | Privacy policy | Copyright © 2018 Farlex, Inc. | Feedback | For webmasters